Cystatin C is associated with adverse COVID-19 outcomes in diverse populations

Sam O Kleeman, Mattia Cordioli, Paul R H J Timmers, …, Andrea Ganna, Kenneth Baillie, Tobias Janowitz

• DOI: 10.1016/j.isci.2022.105040
• PMID: 36062073
• PMCID: PMC9428108